Align Technology Executive to Present at Upcoming Financial Conferences

SANTA CLARA, Calif., Sept. 4 Align Technology,Inc. (Nasdaq: ALGN), the inventor of Invisalign(R), a proprietary method ofstraightening teeth without wires and brackets, announced today that Thomas M.Prescott, President and Chief Executive Officer of Align Technology, isscheduled to speak at two upcoming financial conferences in New York. Allpresentations, as noted below, will be web cast live via the Internet onAlign's web site at http://investor.aligntech.com. An archived replay willremain on the web site for one month. Details follow:

About Align Technology, Inc.

Align Technology designs, manufactures and markets Invisalign, aproprietary method for treating malocclusion, or the misalignment of teeth.Invisalign corrects malocclusion using a series of clear, nearly invisible,removable appliances that gently move teeth to a desired final position.Because it does not rely on the use of metal or ceramic brackets and wires,Invisalign significantly reduces the aesthetic and other limitationsassociated with braces. Invisalign is appropriate for treating adults andolder teens. Align Technology was founded in March 1997 and received FDAclearance to market Invisalign in 1998.

To learn more about Invisalign or to find a certified Invisalign doctor inyour area, please visit http://www.invisalign.com or call 1-800-INVISIBLE.Conference: Bear Stearns 20th Annual Healthcare Conference Date: Tuesday, September 11, 2007 Presentation: 11:00 to 11:25 a.m. Eastern Time Breakout: 11:30 to 11:55 a.m. Eastern Time Conference: UBS Global Life Sciences Conference Date: Tuesday, September 25, 2007 Presentation: 11:00 to 11:25 a.m. Eastern Time Breakout: 11:30 to 11:55 a.m. Eastern Time

SOURCE Align Technology, Inc.

Latest Press Release on General News

Precision oncology company Flindr Therapeutics announces €20 million Series A financing to advance first-in-class small molecule inhibitors

V-Bio Ventures leads international syndicate which includes Johnson & Johnson Innovation – JJDC, Inc., QBIC Fund, Flanders Future Tech Fund, Curie Capital as well as seed investor...

Rett Syndrome Research Trust Partners with Vivalink to Shift Symptom Assessment Paradigms in Rett Syndrome

Vivalink's remote patient monitoring solutions accelerate research into rare neurological disorder CAMPBELL, Calif. , April 23, 2024 /PRNewswire/ -- Vivalink , a leading pro...

World IBS Day - April 19th: Raising Awareness for Everyone with IBS

Debunking myths about Irritable Bowel Syndrome TORONTO , April 18, 2024 /PRNewswire/ -- IBS is a chronic gastrointestinal disorder with symptoms like abdominal pain, bloating,...

Important step taken on the Canada Disability Benefit in Budget 2024, but funding falls short

More work must be done to lift Canadians with disabilities out of poverty TORONTO , April 17, 2024 /CNW/ - The federal government has taken an important step on the Canada Di...

Hydrinity Accelerated Skin Science Introduces MicroFusion Technology and Expands Facial Skincare Line with PRELUDE Facial Treatment Cleanser and HYDRI-C Vitamin C Moisturizer

The Next Generation Technology with the Power to Transform Skin MONROE, La. , April 15, 2024 /PRNewswire/ -- Hydrinity Accelerated Skin Science announced today the launch of t...